Correspondence to Dr Markus A Möhlenbruch, Department of Neuroradiology, Heidelberg University Hospital, 69120 Heidelberg, Germany; markus.moehlenbruch{at}med.uni-heidelberg.de Background ...

1 Institute for Diagnostic and Interventional Neuroradiology, University Medical Center Goettingen, Goettingen, Germany 2 Institute of Neuroradiology, University Medical Center Schleswig-Holstein, ...

Background Venous sinus stenting (VSS) is a promising treatment option for medically refractory idiopathic intracranial hypertension (IIH). There are no published studies comparing the performance of ...

Background Identification of emergent large vessel occlusion (ELVO) stroke has become increasingly important with the recent publications of favorable acute stroke thrombectomy trials. Multiple ...

Background In patients with stroke, current guidelines recommend non-invasive vascular imaging to identify intracranial vessel occlusions (VO) that may benefit from endovascular treatment (EVT).

Introduction/Purpose Headache is a nearly universal and often disabling symptom in the acute phase of aneurysmal subarachnoid hemorrhage (aSAH), yet it remains inadequately managed, often requiring ...

Introduction The Pipeline Embolization Device (PED) is a widely used flow-diversion device for treating intracranial aneurysms. Statins, known for their endothelial-stabilizing and anti-inflammatory ...

Objectives To describe a new technique to obtain minimally invasive but efficient vertebral body (VB) reconstruction, augmentation, and stabilization in severe osteoporotic and neoplastic fractures, ...

Background Stroke due to the release of embolic debris during the placement of a stent to correct carotid artery stenosis is a constant procedural and peri-procedural threat. The new all metal Casper ...

Approximately 20% of ischemic strokes involve the posterior circulation, primarily supplied by the vertebrobasilar system. While much is known about the stroke risk of vertebrobasilar stenotic disease ...

Background and Purpose Embolization is the first-line treatment for dural arteriovenous fistulas (dAVF). The precipitating hydrophobic injectable liquid (PHIL) embolic agent is a non-adhesive ...